KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other financing activities (2016 - 2025)

Historic Other financing activities for Astrana Health (ASTH) over the last 16 years, with Q3 2025 value amounting to $7.8 million.

  • Astrana Health's Other financing activities rose 2486.36% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year increase of 7439.87%. This contributed to the annual value of $34.8 million for FY2024, which is 5792.65% up from last year.
  • Latest data reveals that Astrana Health reported Other financing activities of $7.8 million as of Q3 2025, which was up 2486.36% from $11.8 million recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Other financing activities peaked at $35.4 million during Q4 2024, and registered a low of -$679000.0 during Q4 2021.
  • Its 5-year average for Other financing activities is $9.9 million, with a median of $6.8 million in 2024.
  • In the last 5 years, Astrana Health's Other financing activities skyrocketed by 1957586.21% in 2023 and then soared by 918.33% in 2024.
  • Astrana Health's Other financing activities (Quarter) stood at -$679000.0 in 2021, then soared by 2461.41% to $16.0 million in 2022, then surged by 37.46% to $22.0 million in 2023, then surged by 60.75% to $35.4 million in 2024, then plummeted by 78.04% to $7.8 million in 2025.
  • Its Other financing activities stands at $7.8 million for Q3 2025, versus $11.8 million for Q2 2025 and $17.2 million for Q1 2025.